With our extensive experience in pharmacological research and development, we offer advice and practical support in all areas of new drug development with particular emphasis and expertise in plant secondary metabolites as novel therapeutic agents.
We can design and manage your clinical study for you, and help in all areas of clinical research, from writing the protocol to the development and validation of biomarkers for use as companion diagnostics to support new drug launches or as pharmacodynamic endpoints for clinical and research studies.
We also provide pharmacogenomic and clinical testing services, supporting pre-clinical & clinical trials for different therapeutic areas, with a particular expertise in antimicrobials.
The emerging interest in pharmacogenomics is comprehensively covered to aid the clinical development of new diagnostic, prognostic and predictive tests as well as supporting drug development pipeline studies from target identification through to clinical studies and trials.
Please email safety@oxford.bio for more information.